Christiane E Angermann Selected Research

Micro-Electrical-Mechanical Systems

1/2022	Less loop diuretic use in patients on sacubitril/valsartan undergoing remote pulmonary artery pressure monitoring.
10/2020	Pulmonary artery pressure-guided therapy in ambulatory patients with symptomatic heart failure: the CardioMEMS European Monitoring Study for Heart Failure (MEMS-HF).
11/2018	Safety and feasibility of pulmonary artery pressure-guided heart failure therapy: rationale and design of the prospective CardioMEMS Monitoring Study for Heart Failure (MEMS-HF).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christiane E Angermann Research Topics

Disease

42	Heart Failure 01/2022 - 03/2003
6	Cardiomyopathies (Cardiomyopathy) 01/2022 - 10/2006
5	Systolic Heart Failure 01/2017 - 04/2007
4	Heart Diseases (Heart Disease) 07/2010 - 03/2004
3	Inflammation (Inflammations) 12/2009 - 03/2004
2	Fatigue 04/2019 - 06/2011
2	Chronic Obstructive Pulmonary Disease (COPD) 08/2012 - 02/2012
2	Chronic Disease (Chronic Diseases) 06/2011 - 01/2006
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 07/2007 - 03/2003
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2005 - 09/2003
2	Myocardial Infarction 07/2004 - 03/2003
2	Cardiomegaly (Heart Hypertrophy) 03/2004 - 09/2003
1	Renal Insufficiency (Renal Failure) 01/2022
1	Ischemia 01/2020
1	Atrial Fibrillation 04/2019
1	Neoplasms (Cancer) 01/2019
1	Mood Disorders (Mood Disorder) 12/2018
1	Acquired Immunodeficiency Syndrome (AIDS) 02/2018
1	Body Weight (Weight, Body) 06/2017
1	Death (Near-Death Experience) 01/2017
1	Muscle Weakness 06/2011
1	Edema (Dropsy) 02/2011
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 02/2011
1	Hyperuricemia 02/2011
1	Essential Hypertension 12/2009
1	Fibrosis (Cirrhosis) 12/2009
1	Immunoglobulin Light-chain Amyloidosis 03/2008
1	Amyloidosis 03/2008
1	Pathologic Constriction (Stenosis) 06/2007
1	Hypercholesterolemia 04/2007

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2009
4	Natriuretic PeptidesIBA 06/2017 - 09/2004
3	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 01/2021
3	SodiumIBA 01/2021 - 04/2007
3	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2019 - 04/2007
3	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2016 - 04/2007
3	AutoantibodiesIBA 07/2010 - 10/2006
2	empagliflozinIBA 01/2022 - 01/2022
2	Sodium-Glucose Transport ProteinsIBA 01/2022 - 01/2022
2	DiureticsIBA 01/2022 - 02/2011
2	pro-brain natriuretic peptide (1-76)IBA 04/2019 - 09/2004
2	ProlactinIBA 09/2017 - 11/2015
2	Bromocriptine (Parlodel)FDA LinkGeneric 09/2017 - 11/2015
2	Escitalopram FDA Link 10/2016 - 06/2016
2	Serotonin (5 Hydroxytryptamine)IBA 06/2016 - 12/2007
2	Angiotensin Receptor AntagonistsIBA 04/2015 - 02/2011
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2015 - 02/2011
2	AldosteroneIBA 03/2015 - 04/2007
2	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 03/2015 - 04/2007
2	Bronchodilator Agents (Bronchodilators)IBA 08/2012 - 02/2012
2	GoldIBA 08/2012 - 02/2012
2	CholesterolIBA 02/2011 - 11/2009
2	NF-kappa B (NF-kB)IBA 09/2004 - 03/2003
2	Proteins (Proteins, Gene)FDA Link 07/2004 - 03/2003
2	p38 Mitogen-Activated Protein KinasesIBA 07/2004 - 09/2003
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2022
1	AntigensIBA 01/2021
1	SymportersIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	CreatinineIBA 01/2020
1	hydroxide ionIBA 04/2019
1	Uric Acid (Urate)IBA 04/2019
1	Eicosapentaenoic AcidIBA 01/2019
1	Docosahexaenoic AcidsIBA 01/2019
1	LipidsIBA 01/2019
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2019
1	Troponin IIBA 04/2017
1	Indicators and Reagents (Reagents)IBA 01/2017
1	NeuropeptidesIBA 01/2017
1	AdrenomedullinIBA 01/2017
1	Antidepressive Agents (Antidepressants)IBA 08/2016
1	Mineralocorticoid Receptor AntagonistsIBA 04/2015
1	AndrogensIBA 06/2011
1	Testosterone (Sustanon)FDA Link 06/2011
1	Procollagen Type IIBA 12/2009
1	procollagen Type III-N-terminal peptide (PIIP)IBA 12/2009
1	CollagenIBA 12/2009
1	Collagen Type I (Type I Collagen)IBA 12/2009
1	Collagen Type III (Type III Collagen)IBA 12/2009
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 03/2008
1	Prealbumin (Transthyretin)IBA 03/2008
1	Amyloid (Amyloid Fibrils)IBA 03/2008
1	EnzymesIBA 07/2007
1	Adenosine Monophosphate (AMP)IBA 07/2007
1	AntibodiesIBA 07/2007
1	ImmunosorbentsIBA 07/2007
1	Adenosine (Adenocard)FDA LinkGeneric 06/2007
1	C-Reactive ProteinIBA 04/2007
1	Atrial Natriuretic Factor (ANF)IBA 09/2004
1	Transcription Factors (Transcription Factor)IBA 09/2004
1	Superoxides (Superoxide)IBA 07/2004
1	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 07/2004

Therapy/Procedure

12	Therapeutics 01/2022 - 01/2006
8	Drug Therapy (Chemotherapy) 01/2022 - 09/2004
3	Micro-Electrical-Mechanical Systems 01/2022 - 11/2018
3	Patient Readmission 05/2015 - 09/2004
1	Ambulatory Care (Outpatient Care) 12/2019
1	Cognitive Training 08/2016
1	Heart Transplantation (Grafting, Heart) 11/2015